TY - JOUR
KW - Adolescent
KW - Adult
KW - Aged
KW - Child
KW - Clinical Trials as Topic
KW - Dapsone
KW - Drug Therapy, Combination
KW - Female
KW - Humans
KW - leprosy
KW - Male
KW - Middle Aged
KW - Mycobacterium leprae
KW - Nasal Mucosa
KW - Rifampin
KW - Skin
AU - Languillon J
AU - Yawalkar S J
AU - McDougall A C
BT - International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association
C1 - http://www.ncbi.nlm.nih.gov/pubmed/376454?dopt=Abstract
DA - 1979 Mar
IS - 1
J2 - Int. J. Lepr. Other Mycobact. Dis.
LA - eng
PY - 1979
SP - 37
EP - 43
T2 - International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association
TI - Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
VL - 47
SN - 0148-916X
ER -